[go: up one dir, main page]

CN102093967B - A strain of Enterococcus faecium derived from mink and its application - Google Patents

A strain of Enterococcus faecium derived from mink and its application Download PDF

Info

Publication number
CN102093967B
CN102093967B CN2010105696124A CN201010569612A CN102093967B CN 102093967 B CN102093967 B CN 102093967B CN 2010105696124 A CN2010105696124 A CN 2010105696124A CN 201010569612 A CN201010569612 A CN 201010569612A CN 102093967 B CN102093967 B CN 102093967B
Authority
CN
China
Prior art keywords
enterococcus faecium
mdf1104
mink
application
faecium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010105696124A
Other languages
Chinese (zh)
Other versions
CN102093967A (en
Inventor
李光玉
刘晗璐
杨琛杰
钟伟
刘柏阳
李丹丽
王凯英
孙伟丽
赵靖波
常忠娟
赵家平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Boyang Feed Co ltd
Original Assignee
Institute Special Animal and Plant Sciences CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute Special Animal and Plant Sciences CAAS filed Critical Institute Special Animal and Plant Sciences CAAS
Priority to CN2010105696124A priority Critical patent/CN102093967B/en
Publication of CN102093967A publication Critical patent/CN102093967A/en
Application granted granted Critical
Publication of CN102093967B publication Critical patent/CN102093967B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明涉及一种屎肠球菌菌株及其应用。具体涉及的屎肠球菌MDF1104,专利保藏号CGMCC No.4237。还涉及屎肠球菌MDF1104在碳水化合物发酵,胆固醇降解方面的应用;尤其涉及屎肠球菌MDF1104单独应用或与常规载体组合可以增加水貂采食量,日增重,增强机体免疫机能,并且可以预防或治疗水貂季节性腹泻。The invention relates to an Enterococcus faecium strain and application thereof. Specifically related to Enterococcus faecium MDF1104, patent preservation number CGMCC No.4237. It also relates to the application of Enterococcus faecium MDF1104 in carbohydrate fermentation and cholesterol degradation; especially related to the application of Enterococcus faecium MDF1104 alone or in combination with conventional carriers can increase mink feed intake, daily weight gain, enhance the immune function of the body, and can prevent or Treating seasonal diarrhea in minks.

Description

一株水貂源屎肠球菌及其应用A strain of Enterococcus faecium derived from mink and its application

技术领域 technical field

本发明涉及一株从水貂体内分离得到的屎肠球菌,并特别涉及其在毛皮动物日粮中的应用。The invention relates to a strain of Enterococcus faecium isolated from mink, and particularly relates to its application in the ration of fur animals.

技术背景 technical background

微生态制剂是通过改善寄主肠道菌群平衡而发挥有益作用的活的益生菌制剂,以其绿色安全、无毒副作用、无残留的优点逐步成为替代抗生素类添加剂的主力军。肠球菌属细菌在自然界中分布很广,在一些蔬菜和植物中常见,也是人和动物消化道内正常存在的一种微生物,主要定植在回肠和结肠部位。肠球菌作为益生菌的应用主要集中在粪肠球菌和屎肠球菌,屎肠球菌属于乳酸菌,由于它生长速度快,有较好的黏附能力,能产生乳酸及一些抗菌物质,被广泛的用作为益生菌制剂。研究表明屎肠球菌组成的益生菌可提高幼年畜禽的体增重,提高营养物质消化率,改善饲料报酬,减少腹泻比率,缓解应激状况,降低死亡率。肠球菌除具备以上功能外,还可直接参与胆固醇的代谢,并对异常代谢进行调整,使之恢复正常。肠球菌作为微生态制剂被广泛的应用于肉鸡、育肥猪、育肥牛、仔猪和奶牛生产中。此外,微生态制剂对机体有明显的免疫促进作用,可以促进新生儿肠道免疫系统的发育,也可以促进肠道黏膜局部和系统免疫功能,对特异性和非特异性免疫应答均有调节作用,维持机体在健康状态时免疫功能的正常水平。尽管益生菌具有以上众多免疫调节作用,但对菌种来说,不仅种属之间免疫效果有差异,而且菌株与菌株之间也有不同。此外,摄入时间、供给方式和添加量等方面对免疫调节效果也有影响。宿主也因品种、年龄、生理状况、生活环境的差异,而产生不同的效果。Microecological preparations are live probiotic preparations that play a beneficial role by improving the balance of the host's intestinal flora. With their advantages of green safety, no toxic side effects, and no residues, they have gradually become the main force to replace antibiotic additives. Bacteria of the genus Enterococcus are widely distributed in nature and are common in some vegetables and plants. They are also a type of microorganisms that normally exist in the digestive tract of humans and animals, and are mainly colonized in the ileum and colon. The application of Enterococcus as a probiotic mainly focuses on Enterococcus faecalis and Enterococcus faecium. Enterococcus faecium belongs to lactic acid bacteria. Because it grows fast, has good adhesion ability, and can produce lactic acid and some antibacterial substances, it is widely used as Probiotic preparations. Studies have shown that the probiotics composed of Enterococcus faecium can increase the body weight of young livestock and poultry, improve the digestibility of nutrients, improve feed remuneration, reduce the rate of diarrhea, relieve stress, and reduce mortality. In addition to the above functions, Enterococcus can also directly participate in the metabolism of cholesterol, and adjust the abnormal metabolism to make it return to normal. As a microecological agent, Enterococcus is widely used in the production of broiler chickens, fattening pigs, fattening cattle, piglets and dairy cows. In addition, probiotics have obvious immune-promoting effects on the body, can promote the development of the neonatal intestinal immune system, and can also promote the local and systemic immune function of the intestinal mucosa, and can regulate both specific and non-specific immune responses. Maintain the normal level of immune function when the body is in a healthy state. Although probiotics have many of the above-mentioned immunomodulatory effects, for bacterial species, not only are there differences in immune effects between species, but also differences between strains. In addition, the intake time, supply method and addition amount also have an impact on the immune regulation effect. The host also produces different effects due to differences in species, age, physiological conditions, and living environments.

屎肠球菌在环境中广泛存在,并且属于肠道共生菌,在很多动物新出生的2~3d内占优势地位,并且是一种兼性厌氧的乳酸菌,非常适合于生产和应用。目前市场上已有很多产品中包含屎肠球菌菌株,如韩国的“妈咪爱”,德国和瑞典生产的益生菌制品Ventrux、Bioflorin和Fiormil等,其活菌数大约为108-9个/g产品,目前含屎肠球菌的制品也已被广泛的应用于动物生产中,如韩国生产的饲料添加剂“优比他”等。围产期奶牛饲喂含有屎肠球菌的直接饲用微生物能够促进草料在瘤胃中消化,增加产奶量。肉牛饲喂含有屎肠球菌的直接饲用微生物能够促进肉牛适应高精料日粮,防止酸中毒。应用得当的屎肠球菌不仅可以促进营养物质消化吸收,降低血清胆固醇含量,维持肠道菌群平衡,还可以调节机体免疫功能,刺激胸腺、脾脏和法氏囊等免疫器官的发育,增强巨噬细胞的吞噬活性,活化肠道相关淋巴组织,促进免疫球蛋白A的生成,调节机体的免疫功能。Enterococcus faecium exists widely in the environment and belongs to the intestinal symbiotic bacteria. It is dominant in many animals within 2 to 3 days after birth, and is a facultative anaerobic lactic acid bacteria, which is very suitable for production and application. At present, there are many products on the market that contain Enterococcus faecium strains, such as South Korea's "Mami Love", probiotic products Ventrux, Bioflorin and Fiormil produced in Germany and Sweden, etc., the number of live bacteria is about 10 8-9 / g products, currently products containing Enterococcus faecium have also been widely used in animal production, such as the feed additive "Ubita" produced in South Korea. Feeding direct-fed microorganisms containing Enterococcus faecium to dairy cows during the transition period can promote forage digestion in the rumen and increase milk production. Feeding beef cattle direct feed microorganisms containing Enterococcus faecium can promote the adaptation of beef cattle to high-concentrate diets and prevent acidosis. Properly applied Enterococcus faecium can not only promote the digestion and absorption of nutrients, reduce serum cholesterol levels, maintain the balance of intestinal flora, but also regulate the immune function of the body, stimulate the development of immune organs such as the thymus, spleen and bursa of Fabricius, and enhance macrophages. Phagocytic activity of cells, activation of intestinal-associated lymphoid tissue, promotion of immunoglobulin A production, regulation of immune function of the body.

关于乳酸菌添加剂,在毛皮动物生产中的研究与应用,国内外研究较少,本发明基于益生菌添加剂的益生作用效果,提出了一株来源于毛皮动物体内的安全,稳定,高活性的乳酸菌,并对其优势作用进行检测。Regarding the lactic acid bacteria additive, the research and application in the production of fur animals is less researched at home and abroad. Based on the probiotic effect of the probiotic additive, the present invention proposes a safe, stable and highly active lactic acid bacteria derived from fur animals. and test its advantages.

发明内容 Contents of the invention

从健康成年水貂肠道内分离乳酸菌,取小肠内容物20g,加入100ml无菌水中,摇床震荡30min,使颗粒物质充分溶解,梯度稀释,利用倾注培养法进行分离培养,37℃培养72h选择具有溶钙圈的菌落,采用平板划线的方式纯化,纯化3-4代,镜检,将纯化后的乳酸菌接入MRS液体培养基中,检测其微生物学特性,如形态学、生理学特性(表1)以及糖分解代谢(表2)的能力,检测其体外培养对胆固醇的降解功能(表3)。进行小鼠安全性(表4)检测以及对水貂生产性能(表5)的影响。Isolate lactic acid bacteria from the intestinal tract of healthy adult mink, take 20g of small intestinal content, add 100ml of sterile water, and shake on a shaker for 30min to fully dissolve the particulate matter, gradient dilution, isolation and culture by pouring culture method, 37 ° C for 72 hours to select those with soluble bacteria The colony of the calcium circle was purified by streaking on a plate, purified for 3-4 generations, and examined under a microscope. The purified lactic acid bacteria were inserted into the MRS liquid medium to detect their microbiological characteristics, such as morphological and physiological characteristics (Table 1 ) and the ability of sugar catabolism (Table 2), and the degradation function of cholesterol in vitro culture (Table 3). Carry out mouse safety (Table 4) detection and the impact on mink production performance (Table 5).

该屎肠球菌MDF1104已于2010年10月21日于中国微生物菌种保藏管理委员会普通微生物中心(地址:中国北京市朝阳区北辰西路1号院3号,中国科学院微生物研究所)保藏,保藏号CGMCC No.4237。其分类命名为:屎肠球菌,拉丁名:Enterococcusfaecium。The Enterococcus faecium MDF1104 was preserved on October 21, 2010 in the General Microbiology Center of the China Committee for the Collection of Microbial Cultures (Address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, China, Institute of Microbiology, Chinese Academy of Sciences) No. CGMCC No.4237. Its classification is named: Enterococcus faecium, Latin name: Enterococcusfaecium.

附图说明 Description of drawings

图1屎肠球菌MDF1104在体外培养条件下对胆固醇的降解,横坐标为培养时间(单位:小时),纵坐标为降解率(%)。Fig. 1 Degradation of cholesterol by Enterococcus faecium MDF1104 under in vitro culture conditions, the abscissa is the culture time (unit: hour), and the ordinate is the degradation rate (%).

下面结合实施例和图进一步说明本发明:Below in conjunction with embodiment and figure further illustrate the present invention:

实施例ⅠExample I

屎肠球菌MDF1104形态学观察、显微镜检以及生理生化指标检测Morphological observation, microscopic examination and detection of physiological and biochemical indicators of Enterococcus faecium MDF1104

无菌条件下用接种环挑取培养18-24h的屎肠球菌MDF1104,涂于干净的载玻片上,制片,革兰氏染色进行形态学及染色结果观察。无菌条件下将屎肠球菌接种于相应的培养基或培养条件下,进行生理生化指标的检测观察,检测结果见表1Under sterile conditions, use an inoculation loop to pick up Enterococcus faecium MDF1104 cultured for 18-24 hours, smear it on a clean glass slide, make slides, and observe the morphology and staining results with Gram staining. Enterococcus faecium was inoculated in the corresponding medium or culture conditions under aseptic conditions, and the physiological and biochemical indicators were detected and observed. The test results are shown in Table 1

表1屎肠球菌MDF1104形态学与理化试验结果Table 1 Morphological and physicochemical test results of Enterococcus faecium MDF1104

  检测指标 Detection Indicator   特性 Features   形态学 Morphology   球形,两个成链或散在 Spherical, two chained or scattered   革兰氏染色 a   阳性 Positive   形成芽孢 Sporulation   否 no   接触酶 Catalase   - -

  氧化酶 Oxidase   - -   空气中生长 grow in air   + +   65℃生长 Grow at 65°C   + +   45℃生长 Grow at 45°C   + +   15℃生长 Grow at 15°C   + +   pH值(培养24h) pH value (cultivation 24h)   4.29 4.29   6.5%氯化钠生长 6.5% NaCl growth   + +   pH9.6生长 pH9.6 growth   + +   pH4.5生长 pH4.5 growth   + +

实施例ⅡExample II

屎肠球菌MDF1104对不同碳水化合物发酵活性检测Detection of different carbohydrate fermentation activities of Enterococcus faecium MDF1104

无菌条件下,用接种环挑取少许生长旺盛的,培养18-24h的屎肠球菌MDF1104,接种入北京陆桥技术有限责任公司生产的不同糖发酵管内,37℃恒温培养18-24h,观察发酵液颜色变化,以判断对不同碳水化合物的发酵情况。Under sterile conditions, use an inoculation loop to pick a small amount of Enterococcus faecium MDF1104 that grows vigorously, and culture it for 18-24 hours, inoculate it into different sugar fermentation tubes produced by Beijing Land Bridge Technology Co., Ltd., and culture it at a constant temperature of 37°C for 18-24 hours, and observe the fermentation The color of the liquid changes to judge the fermentation of different carbohydrates.

表2屎肠球菌MDF1104不同碳水化合物发酵活性Table 2 Fermentation activity of different carbohydrates of Enterococcus faecium MDF1104

  检测指标 Detection Indicator   特性 Features   检测指标 Detection Indicator   特性 Features   葡萄糖 Glucose   + +   棉籽糖 Raffinose   + +   甘露糖 Mannose   + +   山梨醇 Sorbitol   + +   松三糖 Melezitose   - -   蜜二糖 Melibiose   + +   果糖 Fructose   + +   半乳糖 Galactose   + +   水杨苷 Salicin   + +   甘露醇 Mannitol   + +   苦杏仁苷 Laetrile   + +   阿拉伯糖 Arabic candy   + +   核糖 Ribose   + +   葡萄糖酸钠 Sodium Gluconate   - -   海藻糖 Trehalose   + +   蔗糖 Sucrose   + +   木糖 xylose   + +   纤维二糖 Cellobiose   + +   鼠李糖 D   + +   七叶灵 Aesculin   + +   麦芽糖 Maltose   + +   发酵葡萄糖产气 Fermenting glucose to produce gas   - -   乳糖 Lactose   + +

由表1,2可知,屎肠球菌MDF1104,革兰氏染色阳性,可在较广泛温度范围内生长,24h培养产酸能力强,可广泛利用碳水化合物产生能量,是一株性状优良的乳酸菌。It can be seen from Tables 1 and 2 that Enterococcus faecium MDF1104 is Gram-positive, can grow in a wide temperature range, has strong acid production ability after 24-hour culture, and can widely use carbohydrates to generate energy. It is a lactic acid bacterium with excellent characteristics.

实施例ⅢExample III

屎肠球菌MDF1104在体外培养过程中对胆固醇的降解作用Cholesterol degradation by Enterococcus faecium MDF1104 in vitro

将纯化培养后的屎肠球菌MDF1104,接种入新配制并灭菌的MRS液体培养基中,37℃培养18-24小时,每隔四小时取样,离心取上清,利用邻苯二甲醛法测定24h内乳酸菌对胆固醇的降解能力。Inoculate the purified and cultivated Enterococcus faecium MDF1104 into the newly prepared and sterilized MRS liquid medium, culture at 37°C for 18-24 hours, take samples every four hours, centrifuge to get the supernatant, and use the o-phthalaldehyde method to determine The ability of lactic acid bacteria to degrade cholesterol within 24 hours.

表3屎肠球菌MDF1104对胆固醇的降解率Table 3 Degradation rate of Enterococcus faecium MDF1104 to cholesterol

  取样时间 sampling time   胆固醇降解率% Cholesterol degradation rate%   4 4   38.45 38.45   8 8   32.05 32.05   12 12   32.05 32.05   16 16   32.55 32.55   24 twenty four   31.07 31.07

由表3和附图1可知,屎肠球菌MDF1104,在体外培养条件下可以降解胆固醇,并且在整个培养期均可高效降解,平均降解率达到33.23%,在对数分裂期达到最高为38.45%,由此说明水貂源屎肠球菌MDF1104对胆固醇有较好的降解性,并且在体外培养期内其降解效率下降不大,由此也说明MDF1104对高胆固醇食品或饲料的降解具有其独特优势。It can be seen from Table 3 and Figure 1 that Enterococcus faecium MDF1104 can degrade cholesterol under in vitro culture conditions, and can be degraded efficiently throughout the culture period, with an average degradation rate of 33.23%, and a maximum of 38.45% in the logarithmic division phase , which shows that the mink-derived Enterococcus faecium MDF1104 has a good degradability to cholesterol, and its degradation efficiency does not decrease much during the in vitro culture period, which also shows that MDF1104 has its unique advantages in the degradation of high-cholesterol food or feed.

实施例ⅣExample IV

屎肠球菌MDF1104对小白鼠安全性及生产性能指标的影响Effects of Enterococcus faecium MDF1104 on the safety and production performance indexes of mice

将屎肠球菌MDF1104接入10ml液体培养基中,接种量1%,37℃培养18h,5000rmp/min离心10分钟,用生理盐水稀释为107cfu/ml和109cfu/ml。选取健康的成年昆明系小白鼠,每组15只,实验组每天每只经口灌注不同浓度的MDF1104稀释液0.3ml,对照组每日灌注等量的生理盐水,连续灌注20天,观察10天,每天进行观察,记录采食情况,体重情况。定期称重,每日监测采食情况,30d时进行屠宰实验,称量胸腺,脾脏重量,计算免疫器官指数。Inoculate Enterococcus faecium MDF1104 into 10ml of liquid medium with an inoculum size of 1%, culture at 37°C for 18 hours, centrifuge at 5000rmp/min for 10 minutes, and dilute to 10 7 cfu/ml and 10 9 cfu/ml with physiological saline. Select healthy adult Kunming mice, 15 mice in each group, each mouse in the experimental group was orally perfused with 0.3ml of MDF1104 dilution solution of different concentrations every day, and the control group was perfused with the same amount of normal saline every day, continuous perfusion for 20 days, and observation for 10 days , observe every day, record the situation of food intake and body weight. Regular weighing, daily monitoring of feed intake, slaughter experiment at 30 days, weighing of thymus, spleen weight, calculation of immune organ index.

表4.屎肠球菌MDF1104对小白鼠安全性及生产性能指标影响Table 4. Effect of Enterococcus faecium MDF1104 on the safety and production performance indicators of mice

  组别 group   死亡只数 Only number of deaths  平均日增重g Average daily weight gain g  平均日采食量g Average daily feed intake g   免疫器官指数 Immune Organ Index   对照组 control group   2 2   9.90 9.90   12.98 12.98   0.57% 0.57%   MDF1104-107 MDF1104-10 7   0 0   10.80 10.80   18.19 18.19   0.56% 0.56%   MDF1104-109 MDF1104-10 9   0 0   11.63 11.63   18.27 18.27   0.59% 0.59%

由表4可知,水貂源的屎肠球菌MDF1104,以不同剂量灌注小鼠,未有小鼠死亡,并且添加MDF1104组小鼠的日采食量以及平均日增重均显著高于对照组,免疫器官指数低剂量组低于对照组,高剂量组略高于对照组。由此可知,屎肠球菌MDF1104,对小白鼠无致死性。并且对小白鼠的日增重及平均日采食量具有促进作用,并且高剂量组具有促进小鼠免疫功能的作用。It can be seen from Table 4 that the mice were perfused with different doses of Enterococcus faecium MDF1104 from mink, and no mice died, and the daily feed intake and average daily weight gain of the mice in the MDF1104 group were significantly higher than those in the control group. The organ index of the low-dose group was lower than that of the control group, and that of the high-dose group was slightly higher than that of the control group. It can be known that Enterococcus faecium MDF1104 is not lethal to mice. And it can promote the daily weight gain and average daily feed intake of mice, and the high-dose group can promote the immune function of mice.

实施例ⅤExample V

屎肠球菌MDF1104对水貂生产性能的影响Effect of Enterococcus faecium MDF1104 on the performance of mink

将屎肠球菌按1%的接种量,接入液体培养基中,37℃发酵24h,选取健康的育成期水貂,每组20只,试验组每天每只随饲料给饲109cfu/g干物质的屎肠球菌MDF1104,对照组不添加,定期称重,每日监测采食情况,跟踪每组水貂腹泻情况,连续饲喂30天,屠宰,称量免疫器官重量,计算免疫器官指数。Inoculate Enterococcus faecium into liquid culture medium at 1% inoculum amount, ferment at 37°C for 24 hours, select healthy minks in the breeding period, 20 for each group, and feed each mink with feed 10 9 cfu/g dry per day in the test group. The substance Enterococcus faecium MDF1104 was not added to the control group, and the control group was weighed regularly. The feeding situation was monitored daily, and the diarrhea situation of each mink was tracked. They were fed continuously for 30 days, slaughtered, and the weight of the immune organs was weighed to calculate the immune organ index.

表5屎肠球菌MDF1104对水貂生产性能的影响Table 5 Effect of Enterococcus faecium MDF1104 on mink performance

  组别 group   腹泻只数 Only a few diarrhea   死亡只数 Only number of deaths  平均日增重g Average daily weight gain g  平均日采食量g Average daily feed intake g  免疫器官指数g Immune organ index g   对照组 control group   11 11   4 4   22.28 22.28   368.81 368.81   0.36 0.36   MDF1104-109cfuMDF1104-10 9 cfu   4 4   1 1   23.33 23.33   384.38 384.38   0.40 0.40

由表5可知,在育成期水貂日粮中添加屎肠球菌MDF1104,可以降低在8月末到9月初期间水貂季节性腹泻的发病率,与对照组相比,腹泻率下降40%,死亡率下降10%,可明显提高水貂日采食量4%以上,平均日增重速度增加约5%,免疫器官指数略有增加。It can be seen from Table 5 that adding Enterococcus faecium MDF1104 to the mink diet during the breeding period can reduce the incidence of seasonal diarrhea in mink during the period from the end of August to the beginning of September. Compared with the control group, the diarrhea rate decreased by 40%, and the mortality rate decreased. 10%, can significantly increase the mink daily feed intake by more than 4%, the average daily weight gain rate increases by about 5%, and the immune organ index increases slightly.

结论in conclusion

上述结果表明,本发明所涉及的屎肠球菌MDF1104,可以增加小鼠及水貂的日采食量及日增重,增强动物的免疫机能,屎肠球菌MDF1104单独应用或者与常规载体组合,可以预防水貂季节性腹泻的发生,改善动物的生产性能。The above results show that Enterococcus faecium MDF1104 involved in the present invention can increase the daily feed intake and daily gain of mice and minks, and enhance the immune function of animals. Enterococcus faecium MDF1104 can be used alone or combined with conventional carriers to prevent Occurrence of seasonal diarrhea in mink, improved animal performance.

Claims (3)

1. a faecium (Enterococcus faecium) MDF1104 preserves numbering CGMCC No.4237.
2. faecium MDF1104 claimed in claim 1 is improving the mink daily ingestion amount, the application of day weight gain aspect.
3. feed pre-mixing material, feed pre-mixing material contains the described faecium MDF1104 of claim 1.
CN2010105696124A 2010-12-02 2010-12-02 A strain of Enterococcus faecium derived from mink and its application Expired - Fee Related CN102093967B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105696124A CN102093967B (en) 2010-12-02 2010-12-02 A strain of Enterococcus faecium derived from mink and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105696124A CN102093967B (en) 2010-12-02 2010-12-02 A strain of Enterococcus faecium derived from mink and its application

Publications (2)

Publication Number Publication Date
CN102093967A CN102093967A (en) 2011-06-15
CN102093967B true CN102093967B (en) 2013-01-30

Family

ID=44127234

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105696124A Expired - Fee Related CN102093967B (en) 2010-12-02 2010-12-02 A strain of Enterococcus faecium derived from mink and its application

Country Status (1)

Country Link
CN (1) CN102093967B (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10322151B2 (en) 2015-06-15 2019-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
US10391130B2 (en) 2015-06-15 2019-08-27 4D Pharma Research Limited Compositions comprising bacterial strains
US10391128B2 (en) 2015-11-23 2019-08-27 4D Pharma Research Limited Compositions comprising bacterial strains
US10456444B2 (en) 2014-12-23 2019-10-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
US10471108B2 (en) 2015-11-20 2019-11-12 4D Pharma Research Limited Compositions comprising bacterial strains
US10485830B2 (en) 2016-12-12 2019-11-26 4D Pharma Plc Compositions comprising bacterial strains
US10493112B2 (en) 2015-06-15 2019-12-03 4D Pharma Research Limited Compositions comprising bacterial strains
US10500237B2 (en) 2015-06-15 2019-12-10 4D Pharma Research Limited Compositions comprising bacterial strains
US10583158B2 (en) 2016-03-04 2020-03-10 4D Pharma Plc Compositions comprising bacterial strains
US10610548B2 (en) 2016-07-13 2020-04-07 4D Pharma Plc Compositions comprising bacterial strains
US10610550B2 (en) 2015-11-20 2020-04-07 4D Pharma Research Limited Compositions comprising bacterial strains
US10736926B2 (en) 2015-06-15 2020-08-11 4D Pharma Research Limited Compositions comprising bacterial strains
US10744166B2 (en) 2015-11-23 2020-08-18 4D Pharma Research Limited Compositions comprising bacterial strains
US10851137B2 (en) 2013-04-10 2020-12-01 4D Pharma Research Limited Polypeptide and immune modulation
US10987387B2 (en) 2017-05-24 2021-04-27 4D Pharma Research Limited Compositions comprising bacterial strain
US11007233B2 (en) 2017-06-14 2021-05-18 4D Pharma Research Limited Compositions comprising a bacterial strain of the genus Megasphera and uses thereof
US11013773B2 (en) 2011-07-14 2021-05-25 4D Pharma Research Limited Lactic acid bacterial strains
US11123378B2 (en) 2017-05-22 2021-09-21 4D Pharma Research Limited Compositions comprising bacterial strains
US11123379B2 (en) 2017-06-14 2021-09-21 4D Pharma Research Limited Compositions comprising bacterial strains
US11224620B2 (en) 2016-07-13 2022-01-18 4D Pharma Plc Compositions comprising bacterial strains
US11266698B2 (en) 2011-10-07 2022-03-08 4D Pharma Research Limited Bacterium for use as a probiotic for nutritional and medical applications
US11723933B2 (en) 2014-12-23 2023-08-15 Cj Bioscience, Inc. Composition of bacteroides thetaiotaomicron for immune modulation
US12048720B2 (en) 2017-06-14 2024-07-30 Cj Bioscience, Inc. Compositions comprising bacterial strains

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104862254B (en) * 2015-05-26 2018-02-16 北京好实沃生物技术有限公司 One Enterococcus faecalis HEW A588 and its application
CN105733977B (en) * 2016-01-27 2019-06-14 南昌大学 Probiotic Feed Additives
CN105733978B (en) * 2016-01-27 2019-04-12 南昌大学 One Enterococcus faecalis WEFA23

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026269A1 (en) * 2003-09-04 2005-03-24 Mcdaniel C Steven Microorganism coating components, coatings, and coated surfaces
CN101531986A (en) * 2008-07-23 2009-09-16 中国农业科学院特产研究所 Recombinant strain of mink IFN-Gamma gene
CN101601442A (en) * 2008-11-05 2009-12-16 中国农业科学院特产研究所 1% special compound premix for mink

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026269A1 (en) * 2003-09-04 2005-03-24 Mcdaniel C Steven Microorganism coating components, coatings, and coated surfaces
CN101531986A (en) * 2008-07-23 2009-09-16 中国农业科学院特产研究所 Recombinant strain of mink IFN-Gamma gene
CN101601442A (en) * 2008-11-05 2009-12-16 中国农业科学院特产研究所 1% special compound premix for mink

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11013773B2 (en) 2011-07-14 2021-05-25 4D Pharma Research Limited Lactic acid bacterial strains
US11266698B2 (en) 2011-10-07 2022-03-08 4D Pharma Research Limited Bacterium for use as a probiotic for nutritional and medical applications
US11414463B2 (en) 2013-04-10 2022-08-16 4D Pharma Research Limited Polypeptide and immune modulation
US10851137B2 (en) 2013-04-10 2020-12-01 4D Pharma Research Limited Polypeptide and immune modulation
US10456444B2 (en) 2014-12-23 2019-10-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
US10973872B2 (en) 2014-12-23 2021-04-13 4D Pharma Research Limited Pirin polypeptide and immune modulation
US11723933B2 (en) 2014-12-23 2023-08-15 Cj Bioscience, Inc. Composition of bacteroides thetaiotaomicron for immune modulation
US11389493B2 (en) 2015-06-15 2022-07-19 4D Pharma Research Limited Compositions comprising bacterial strains
US10780134B2 (en) 2015-06-15 2020-09-22 4D Pharma Research Limited Compositions comprising bacterial strains
US10391130B2 (en) 2015-06-15 2019-08-27 4D Pharma Research Limited Compositions comprising bacterial strains
US10500237B2 (en) 2015-06-15 2019-12-10 4D Pharma Research Limited Compositions comprising bacterial strains
US11273185B2 (en) 2015-06-15 2022-03-15 4D Pharma Research Limited Compositions comprising bacterial strains
US11040075B2 (en) 2015-06-15 2021-06-22 4D Pharma Research Limited Compositions comprising bacterial strains
US10736926B2 (en) 2015-06-15 2020-08-11 4D Pharma Research Limited Compositions comprising bacterial strains
US10322151B2 (en) 2015-06-15 2019-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
US10744167B2 (en) 2015-06-15 2020-08-18 4D Pharma Research Limited Compositions comprising bacterial strains
US11433106B2 (en) 2015-06-15 2022-09-06 4D Pharma Research Limited Compositions comprising bacterial strains
US10493112B2 (en) 2015-06-15 2019-12-03 4D Pharma Research Limited Compositions comprising bacterial strains
US10864236B2 (en) 2015-06-15 2020-12-15 4D Pharma Research Limited Compositions comprising bacterial strains
US11331352B2 (en) 2015-06-15 2022-05-17 4D Pharma Research Limited Compositions comprising bacterial strains
US10610550B2 (en) 2015-11-20 2020-04-07 4D Pharma Research Limited Compositions comprising bacterial strains
US10471108B2 (en) 2015-11-20 2019-11-12 4D Pharma Research Limited Compositions comprising bacterial strains
US11058732B2 (en) 2015-11-20 2021-07-13 4D Pharma Research Limited Compositions comprising bacterial strains
US10744166B2 (en) 2015-11-23 2020-08-18 4D Pharma Research Limited Compositions comprising bacterial strains
US10391128B2 (en) 2015-11-23 2019-08-27 4D Pharma Research Limited Compositions comprising bacterial strains
US10583158B2 (en) 2016-03-04 2020-03-10 4D Pharma Plc Compositions comprising bacterial strains
US10960031B2 (en) 2016-07-13 2021-03-30 4D Pharma Plc Compositions comprising bacterial strains
US10610548B2 (en) 2016-07-13 2020-04-07 4D Pharma Plc Compositions comprising bacterial strains
US11224620B2 (en) 2016-07-13 2022-01-18 4D Pharma Plc Compositions comprising bacterial strains
US10967010B2 (en) 2016-07-13 2021-04-06 4D Pharma Plc Compositions comprising bacterial strains
US10610549B2 (en) 2016-07-13 2020-04-07 4D Pharma Plc Composition comprising bacterial strains
US10485830B2 (en) 2016-12-12 2019-11-26 4D Pharma Plc Compositions comprising bacterial strains
US10543238B2 (en) 2016-12-12 2020-01-28 4D Pharma Plc Compositions comprising bacterial strains
US10898526B2 (en) 2016-12-12 2021-01-26 4D Pharma Plc Compositions comprising bacterial strains
US11123378B2 (en) 2017-05-22 2021-09-21 4D Pharma Research Limited Compositions comprising bacterial strains
US11376284B2 (en) 2017-05-22 2022-07-05 4D Pharma Research Limited Compositions comprising bacterial strains
US11382936B2 (en) 2017-05-22 2022-07-12 4D Pharma Research Limited Compositions comprising bacterial strains
US10987387B2 (en) 2017-05-24 2021-04-27 4D Pharma Research Limited Compositions comprising bacterial strain
US11007233B2 (en) 2017-06-14 2021-05-18 4D Pharma Research Limited Compositions comprising a bacterial strain of the genus Megasphera and uses thereof
US11660319B2 (en) 2017-06-14 2023-05-30 4D Pharma Research Limited Compositions comprising bacterial strains
US11123379B2 (en) 2017-06-14 2021-09-21 4D Pharma Research Limited Compositions comprising bacterial strains
US11779613B2 (en) 2017-06-14 2023-10-10 Cj Bioscience, Inc. Compositions comprising a bacterial strain of the genus Megasphera and uses thereof
US12048720B2 (en) 2017-06-14 2024-07-30 Cj Bioscience, Inc. Compositions comprising bacterial strains

Also Published As

Publication number Publication date
CN102093967A (en) 2011-06-15

Similar Documents

Publication Publication Date Title
CN102093967B (en) A strain of Enterococcus faecium derived from mink and its application
CN103598447B (en) Non-antibiotic sucking pig milk replacer and preparation method
CN101580799B (en) A kind of compound probiotics and its application
CN102409015B (en) Composite micro-ecological preparation as well as premixed material and application of preparation in feed additive
CN101671638B (en) New strain of bifidobacterium and fermentative preparation method and application thereof
CN101978849B (en) Composite micro-ecological preparation and application thereof
CN103966124A (en) Compound microecological preparation and additive, as well as premix thereof
CN106906154A (en) One lactobacillus plantarum strain and its feed addictive and feed
CN115094012B (en) Preparation method and application of bacillus coagulans BC-HYC strain microbial inoculum
CN102232479B (en) A kind of preparation technology of bacillus feed additive
WO2008023580A1 (en) Animal feed additive
CN102391962B (en) Enterococcus faecium preparation agent and manufacturing technology thereof
CN102965316B (en) Bacteriocin containing class and the feed addictive of Pediococcus acidilactici, premix and batch
CN101971920A (en) Porcine lactobacillus reuteri lyophilized preparation and preparation method thereof
Moarrab et al. Effect of synbiotic on performance, intestinal morphology, fecal microbial population and blood metabolites of suckling lambs
CN115925832A (en) A kind of lactobacillus and its application in the prevention and control of livestock and poultry bacterial infection
CN103320351B (en) Lactococcus garvieae and biological feed-additive prepared therefrom
CN104263683B (en) Bacillus pumilus 315 and its application with prebiotic effect
JP5499231B2 (en) Animal feed composition containing Lactobacillus plantarum, combined animal feed containing the composition, and method for maintaining or growing the Lactobacillus plantarum in the animal intestine
CN101904411A (en) A kind of compound probiotics and its application
CN110150488A (en) A kind of pig feed additive and its preparation method and application
CN105341425A (en) A kind of pig feed containing antibacterial probiotics and its application
CN117467584B (en) A compound probiotic agent for improving cat intestinal health, preparation method and application
CN106811429B (en) Bacillus subtilis strain, application of feed additive thereof and feed
CN105505808B (en) A kind of compound micro-ecological preparation, additive, premix and batch

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 130112 Jilin province Changchun Jingyue Economic Development Zone Industry Street No. 4899

Patentee after: INSTITUTE OF SPECIAL ANIMAL AND PLANT SCIENCES OF CAAS

Address before: 132109 Jilin Province, Jilin city Changyi district left town Luming Street No. 15

Patentee before: INSTITUTE OF SPECIAL ANIMAL AND PLANT SCIENCES OF CAAS

TR01 Transfer of patent right

Effective date of registration: 20200821

Address after: No.860, Weijia village, laodafang Town, Liaozhong District, Shenyang City, Liaoning Province, 110200

Patentee after: SHENYANG BOYANG FEED Co.,Ltd.

Address before: 130112 Jilin province Changchun Jingyue Economic Development Zone Industry Street No. 4899

Patentee before: INSTITUTE OF SPECIAL ANIMAL AND PLANT SCIENCES OF CAAS

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130130

CF01 Termination of patent right due to non-payment of annual fee